Autoinjectors Global Market Report 2025

Description

An autoinjector is a device designed for self-administering a single, predetermined dose of medication into the body. Typically, it features a spring-loaded syringe that is activated upon firm pressure against the body.

The primary types of autoinjectors are disposable autoinjectors and reusable autoinjectors. The market for disposable autoinjectors involves the sales of devices designed to replace traditional pre-filled syringes, aiming to eliminate psychological barriers by concealing the needle from the patient's view. These autoinjectors integrate a spring-powered mechanism with a shielded needle for subcutaneous or intramuscular administration of the required drug solution. They find application in various therapies such as rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and others, administered through routes like subcutaneous and intramuscular. Distribution channels include online retailers and pharmacies, and they are utilized in diverse settings, including home care, hospitals, clinics, and others.

The autoinjectors market research report is one of a series of new reports from The Business Research Company that provides autoinjectors market statistics, including autoinjectors industry global market size, regional shares, competitors with an market share, detailed autoinjectors market segments, market trends and opportunities, and any further data you may need to thrive in the autoinjectors industry. This autoinjectors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The autoinjectors market size has grown exponentially in recent years. It will grow from $3.7 billion in 2024 to $4.55 billion in 2025 at a compound annual growth rate (CAGR) of 22.8%. The growth in the historic period can be attributed to increased prevalence of chronic diseases, growth in aging population, rise in biotechnology and pharmaceutical sector, rise in patient preference for self-administration, regulatory support.

The autoinjectors market size is expected to see exponential growth in the next few years. It will grow to $10.07 billion in 2029 at a compound annual growth rate (CAGR) of 22.0%. The growth in the forecast period can be attributed to expansion of Therapeutic applications, rising healthcare costs, increased focus on patient-centered care, telemedicine and remote patient monitoring, emerging markets. Major trends in the forecast period include personalized drug delivery, connected and smart autoinjectors, needle-free autoinjectors, biologic drug delivery, safety and security features.

The rising prevalence of chronic diseases is expected to drive growth in the autoinjectors market in the upcoming years. Chronic diseases are defined as illnesses that last for a year or longer and require ongoing medical attention. Conditions such as heart disease, cancer, rheumatoid arthritis, and diabetes are among the leading causes of mortality and disability worldwide. Autoinjector devices are designed for multiple injections of biologics and hormones in patients who need regular doses for the long-term management of conditions like diabetes and rheumatoid arthritis. For example, in January 2022, research published by the American Cancer Society, a US-based health organization, projected that there would be 609,360 cancer deaths and 1.9 million new cancer cases in the US for that year, which translates to approximately 1,670 fatalities each day. This rising prevalence of chronic diseases is propelling the growth of the autoinjectors market, as these devices offer a convenient and effective solution for patients requiring regular medication.

Rising healthcare expenditure is anticipated to boost the autoinjectors market. Healthcare expenditure refers to the total amount of money spent on healthcare services, goods, and activities within a specific healthcare system or economy over a defined period. Increased healthcare expenditure supports the development, affordability, and accessibility of autoinjectors for patients. Moreover, greater demand for autoinjectors can drive innovation in the field of autoinjector development. As an illustration, according to a report published by the UK's Office for National Statistics in May 2023, healthcare spending in the UK increased by 9.4% in nominal terms and 9.7% in real terms between 2020 and 2021. In 2021, total healthcare expenditure in the UK reached $367.25 billion (£280.7 billion), with pharmaceutical expenditure at $51.84 billion (£39.6 billion), and spending on preventive care more than doubling from 2020, totaling $45.93 billion (£35.1 billion). Thus, rising healthcare expenditures are playing a significant role in propelling the autoinjectors market.

The rise of technological advancements is significantly influencing the autoinjectors market. Key players in the autoinjectors sector are concentrating on developing innovative solutions to fulfill the demand for a delivery mechanism for viscous biologics. For example, in May 2023, Boehringer Ingelheim, a Germany-based pharmaceutical company, announced that its Cyltezo Pen, an autoinjector option for Cyltezo (adalimumab-adbm), received approval from the U.S. Food and Drug Administration (FDA). Cyltezo is authorized for the treatment of various chronic inflammatory diseases. The 40 mg/0.8 mL pre-filled Cyltezo Pen will be available in packs of two, four, and six.

Major companies in the auto-injectors market are focused on developing innovative products to address the growing demand for sustainable drug delivery devices while offering more cost-effective solutions for self-administered drug delivery. One such innovative product is the Qfinity auto-injector platform, designed to be both sustainable and affordable. The platform incorporates durable materials capable of withstanding over 100 injections and features a pre-filled disposable cassette system that minimizes waste. For example, in May 2022, Jabil Inc., a US-based healthcare manufacturing company, introduced the Qfinity auto-injector platform. This platform is a straightforward, reusable, and modular solution for self-administering subcutaneous (SC) drugs, including larger-volume and higher-viscosity medicines. It offers sustainability, cost-effectiveness, versatility, ease of use, accuracy, safety, portability, and durability for self-administered drug delivery.

In April 2022, Halozyme Therapeutics Inc., a US-based biotechnology company, acquired Antares Pharma Inc. for $960 million. This strategic acquisition is aimed at expanding Halozyme Therapeutics Inc.'s portfolio of drug delivery technologies and gaining access to Antares' commercial infrastructure. The acquisition positions them to become a leading company in the field of drug delivery. Antares Pharma Inc. is a US-based pharmaceutical product development company specializing in the development of auto-injectors. This acquisition will likely enhance Halozyme's capabilities in delivering innovative drug delivery solutions, including auto-injectors, to a broader market.

Major companies operating in the autoinjectors market include AbbVie Inc., Mylan N.V., Eli Lilly and Company, Amgen Inc., Becton, Dickinson and Company, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Pfizer Inc., Bayer AG, Biogen Inc., AstraZeneca PLC, Haselmeier GmbH, Owen Mumford Ltd., Gerresheimer AG, Philip Morris International Inc., Oval Medical Technologies Ltd., Solteam Incorporation Co. Ltd., Elcam Medical Group (E3D) Ltd., Jabil Inc., Catalent Inc., SHL Medical AG, West Pharmaceutical Services Inc., Nemera Development S.A., Bespak Europe Ltd., AptarGroup Inc., Consort Medical plc, Terumo Corporation, Nipro Corporation, Medtronic plc, Integra LifeSciences Corporation, OssDsign AB, Xenco Medical LLC, Renishaw plc

North America was the largest region in the autoinjectors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in autoinjectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the autoinjectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The autoinjectors market consists of sales of disposable and reusable autoinjectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Autoinjectors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on autoinjectors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for autoinjectors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The autoinjectors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Disposable Autoinjectors; Reusable Autoinjectors
2) By Therapy: Rheumatoid Arthritis; Multiple Sclerosis; Diabetes; Anaphylaxis; Other Therapies
3) By Route Of Administration: Subcutaneous; Intramuscular
4) By Distribution Channel: Online Retailer; Pharmacy
5) By End User: Home Care Settings; Hospitals And Clinics; Other End-Users
Subsegments:
1) By Disposable Autoinjectors: Single-Use Disposable Autoinjectors; Pre-filled Disposable Autoinjectors
2) By Reusable Autoinjectors: Multi-Use Reusable Autoinjectors; Rechargeable Reusable Autoinjectors
Companies Mentioned: AbbVie Inc.; Mylan N.V.; Eli Lilly and Company; Amgen Inc.; Becton, Dickinson and Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r21032

1. Executive Summary

2. Autoinjectors Market Characteristics

3. Autoinjectors Market Trends And Strategies

4. Autoinjectors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Autoinjectors Growth Analysis And Strategic Analysis Framework

5.1. Global Autoinjectors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Autoinjectors Market Growth Rate Analysis
5.4. Global Autoinjectors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Autoinjectors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Autoinjectors Total Addressable Market (TAM)

6. Autoinjectors Market Segmentation

6.1. Global Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Disposable Autoinjectors
Reusable Autoinjectors
6.2. Global Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Rheumatoid Arthritis
Multiple Sclerosis
Diabetes
Anaphylaxis
Other Therapies
6.3. Global Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Subcutaneous
Intramuscular
6.4. Global Autoinjectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Online Retailer
Pharmacy
6.5. Global Autoinjectors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Home Care Settings
Hospitals And Clinics
Other End-Users
6.6. Global Autoinjectors Market, Sub-Segmentation Of Disposable Autoinjectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single-Use Disposable Autoinjectors
Pre-filled Disposable Autoinjectors
6.7. Global Autoinjectors Market, Sub-Segmentation Of Reusable Autoinjectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Multi-Use Reusable Autoinjectors
Rechargeable Reusable Autoinjectors

7. Autoinjectors Market Regional And Country Analysis

7.1. Global Autoinjectors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Autoinjectors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Autoinjectors Market

8.1. Asia-Pacific Autoinjectors Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Autoinjectors Market

9.1. China Autoinjectors Market Overview
9.2. China Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Autoinjectors Market

10.1. India Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Autoinjectors Market

11.1. Japan Autoinjectors Market Overview
11.2. Japan Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Autoinjectors Market

12.1. Australia Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Autoinjectors Market

13.1. Indonesia Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Autoinjectors Market

14.1. South Korea Autoinjectors Market Overview
14.2. South Korea Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Autoinjectors Market

15.1. Western Europe Autoinjectors Market Overview
15.2. Western Europe Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Autoinjectors Market

16.1. UK Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Autoinjectors Market

17.1. Germany Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Autoinjectors Market

18.1. France Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Autoinjectors Market

19.1. Italy Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Autoinjectors Market

20.1. Spain Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Autoinjectors Market

21.1. Eastern Europe Autoinjectors Market Overview
21.2. Eastern Europe Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Autoinjectors Market

22.1. Russia Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Autoinjectors Market

23.1. North America Autoinjectors Market Overview
23.2. North America Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Autoinjectors Market

24.1. USA Autoinjectors Market Overview
24.2. USA Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Autoinjectors Market

25.1. Canada Autoinjectors Market Overview
25.2. Canada Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Autoinjectors Market

26.1. South America Autoinjectors Market Overview
26.2. South America Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Autoinjectors Market

27.1. Brazil Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Autoinjectors Market

28.1. Middle East Autoinjectors Market Overview
28.2. Middle East Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Autoinjectors Market

29.1. Africa Autoinjectors Market Overview
29.2. Africa Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Autoinjectors Market Competitive Landscape And Company Profiles

30.1. Autoinjectors Market Competitive Landscape
30.2. Autoinjectors Market Company Profiles
- 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Mylan N.V. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Autoinjectors Market Other Major And Innovative Companies

31.1. Johnson & Johnson
31.2. Teva Pharmaceutical Industries Ltd.
31.3. Merck & Co. Inc.
31.4. Pfizer Inc.
31.5. Bayer AG
31.6. Biogen Inc.
31.7. AstraZeneca PLC
31.8. Haselmeier GmbH
31.9. Owen Mumford Ltd.
31.10. Gerresheimer AG
31.11. Philip Morris International Inc.
31.12. Oval Medical Technologies Ltd.
31.13. Solteam Incorporation Co. Ltd.
31.14. Elcam Medical Group (E3D) Ltd.
31.15. Jabil Inc.

32. Global Autoinjectors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Autoinjectors Market

34. Recent Developments In The Autoinjectors Market

35. Autoinjectors Market High Potential Countries, Segments and Strategies

35.1 Autoinjectors Market In 2029 - Countries Offering Most New Opportunities
35.2 Autoinjectors Market In 2029 - Segments Offering Most New Opportunities
35.3 Autoinjectors Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer